[ad_1]
The $22 million investment from ATAI will develop the drug ibogaine which is derived from the iboga plant that has previously been sold as a stimulant …
[ad_2]
Source link
![](https://www.myeboga.com/wp-content/uploads/22-Million-Joint-Venture-To-Purse-Neurochemical-Reset-For-Addiction-500x500.jpg)
[ad_1]
The $22 million investment from ATAI will develop the drug ibogaine which is derived from the iboga plant that has previously been sold as a stimulant …
[ad_2]
Source link
[ad_1]
A joint venture has been set up by ATAI Life Sciences and DemeRX to develop a one and done treatment that will work to give people suffering from addiction a neurochemical reset of sorts using a drug derived from a Western African plant.
The $22 million investment from ATAI will develop the drug ibogaine which is derived from the iboga plant that has previously been sold as a stimulant ...
Continue Reading →